Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lightwave Science is a private U.S. company that develops portable analytical devices for the cannabis and hemp market rather than a therapeutics-focused biotech pipeline. Its flagship product, the Cannalyzer-420, is a handheld or portable near-infrared spectroscopy-based analyzer designed to estimate THC, CBD, and moisture content in cannabis flower samples. The company appears to position itself at the intersection of biotechnology tools, agricultural analytics, and cannabis quality control, serving growers, strain researchers, distributors, extractors, and caregivers. Based on available public information, Lightwave Science is commercial-stage, private, and focused on instrument sales and related educational resources rather than drug development. For biotech analysts, the company is best understood as a specialty life-science instrumentation business with cannabis-focused measurement technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lightwave Science.